These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37738174)

  • 1. Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia.
    Broccoli A; Argnani L; Nanni L; Stefoni V; Pellegrini C; Casadei B; Gugliotta G; Carella M; Coppola PE; Bagnato G; Zinzani PL
    Blood Adv; 2023 Nov; 7(21):6762-6766. PubMed ID: 37738174
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.
    Nieva J; Bethel K; Saven A
    Blood; 2003 Aug; 102(3):810-3. PubMed ID: 12663446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.
    Buckstein R; Patel H; Chesney A; Reis M; Imrie K
    Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
    Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
    Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases.
    Hoffman MA
    Med Oncol; 2011 Dec; 28(4):1537-41. PubMed ID: 20509009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.
    Imamura T; Ohtsuka E; Ogata M; Oka F; Kashima K; Kikuchi H; Nasu M
    Int J Hematol; 2004 Dec; 80(5):432-4. PubMed ID: 15646655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia-Free Survival.
    Amhaz G; Ibrahim A; Usta U; El Cheikh J; Bazarbachi A; Abou Dalle I
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):564-566. PubMed ID: 33994319
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
    Chihara D; Arons E; Stetler-Stevenson M; Yuan CM; Wang HW; Zhou H; Raffeld M; Xi L; Steinberg SM; Feurtado J; James L; Wilson W; Braylan RC; Calvo KR; Maric I; Dulau-Florea A; Kreitman RJ
    J Clin Oncol; 2020 May; 38(14):1527-1538. PubMed ID: 32109194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
    Forconi F; Toraldo F; Sozzi E; Amato T; Raspadori D; Lauria F
    Leuk Lymphoma; 2007 Dec; 48(12):2441-3. PubMed ID: 18067021
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacological management of hairy cell leukemia.
    Ramos Perez J; Ravandi-Kashani F
    Expert Opin Pharmacother; 2020 Aug; 21(11):1337-1344. PubMed ID: 32378970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis.
    Andrasiak I; Rybka J; Wrobel T
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):392-399.e3. PubMed ID: 29685423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of refractory hairy cell leukemia with rituximab].
    Onaka T; Ozumi N; Yonezawa A; Imada K
    Nihon Naika Gakkai Zasshi; 2009 Aug; 98(8):1987-9. PubMed ID: 19764485
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoimmunotherapy for hairy cell leukemia.
    Ravandi F
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine.
    Hoffman M; Auerbach L
    Br J Haematol; 2000 Jun; 109(4):900-1. PubMed ID: 10970137
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
    Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H
    Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine in the treatment of hairy-cell leukaemia.
    Goodman GR; Beutler E; Saven A
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):101-16. PubMed ID: 12670469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.